Oramed to Present at BIO CEO Investor Conference

JERUSALEM, Feb. 6, 2018 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming BIO CEO & Investor Conference, taking place February 12-13, 2018 in New York City.  Nadav Kidron, Chief Executive Officer […]